Insider Transactions in Q2 2024 at Myomo, Inc. (MYO)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 10
2024
|
Micah Mitchell Chief Commercial Officer |
BUY
Payment of exercise price or tax liability
|
Direct |
6,837
+3.31%
|
$20,511
$3.38 P/Share
|
|
Jun 10
2024
|
Harry Kovelman Chief Medical Officer |
BUY
Payment of exercise price or tax liability
|
Direct |
5,347
+3.54%
|
$16,041
$3.38 P/Share
|
|
Jun 10
2024
|
David A Henry Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,620
-2.56%
|
$31,860
$3.38 P/Share
|
|
Jun 05
2024
|
Micah Mitchell Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+19.5%
|
-
|
|
Jun 05
2024
|
David A Henry Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
70,000
+14.45%
|
-
|
|
Jun 05
2024
|
Harry Kovelman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
53,000
+25.99%
|
-
|
|
Jun 05
2024
|
Paul R Gudonis Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
130,000
+11.93%
|
-
|
|
Jun 05
2024
|
Thomas F Kirk |
BUY
Grant, award, or other acquisition
|
Direct |
12,034
+4.62%
|
-
|
|
Jun 05
2024
|
Thomas Aloysius Crowley Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
12,034
+22.26%
|
-
|
|
Jun 05
2024
|
Milton Mayo Morris |
BUY
Grant, award, or other acquisition
|
Direct |
12,034
+9.48%
|
-
|
|
Jun 05
2024
|
Heather C Getz |
BUY
Grant, award, or other acquisition
|
Direct |
12,034
+50.0%
|
-
|
|
Jun 05
2024
|
Amy K. Knapp |
BUY
Grant, award, or other acquisition
|
Direct |
12,034
+11.61%
|
-
|
|
Jun 03
2024
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
121
-0.12%
|
$363
$3.48 P/Share
|
|
May 29
2024
|
Thomas F Kirk |
BUY
Open market or private purchase
|
Direct |
50,000
+17.45%
|
$150,000
$3.5 P/Share
|
|
May 15
2024
|
Harry Kovelman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
35,426
-26.55%
|
$106,278
$3.69 P/Share
|
|
May 03
2024
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
146
-0.11%
|
$438
$3.84 P/Share
|
|
Apr 03
2024
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
146
-0.11%
|
$292
$2.97 P/Share
|